001     119236
005     20240228145428.0
024 7 _ |a 10.1016/j.ctrv.2016.11.010
|2 doi
024 7 _ |a pmid:28006694
|2 pmid
024 7 _ |a 0305-7372
|2 ISSN
024 7 _ |a 1532-1967
|2 ISSN
024 7 _ |a altmetric:14524425
|2 altmetric
037 _ _ |a DKFZ-2017-00026
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Buffart, Laurien M
|b 0
245 _ _ |a Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.
260 _ _ |a Amsterdam [u.a.]
|c 2017
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1511334484_28996
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a This individual patient data meta-analysis aimed to evaluate the effects of exercise on quality of life (QoL) and physical function (PF) in patients with cancer, and to identify moderator effects of demographic (age, sex, marital status, education), clinical (body mass index, cancer type, presence of metastasis), intervention-related (intervention timing, delivery mode and duration, and type of control group), and exercise-related (exercise frequency, intensity, type, time) characteristics. Relevant published and unpublished studies were identified in September 2012 via PubMed, EMBASE, PsycINFO, and CINAHL, reference checking and personal communications. Principle investigators of all 69 eligible trials were requested to share IPD from their study. IPD from 34 randomised controlled trials (n=4519 patients) that evaluated the effects of exercise compared to a usual care, wait-list or attention control group on QoL and PF in adult patients with cancer were retrieved and pooled. Linear mixed-effect models were used to evaluate the effects of the exercise on post-intervention outcome values (z-score) adjusting for baseline values. Moderator effects were studies by testing interactions. Exercise significantly improved QoL (β=0.15, 95%CI=0.10;0.20) and PF (β=0.18, 95%CI=0.13;0.23). The effects were not moderated by demographic, clinical or exercise characteristics. Effects on QoL (βdifference_in_effect=0.13, 95%CI=0.03;0.22) and PF (βdifference_in_effect=0.10, 95%CI=0.01;0.20) were significantly larger for supervised than unsupervised interventions. In conclusion, exercise, and particularly supervised exercise, effectively improves QoL and PF in patients with cancer with different demographic and clinical characteristics during and following treatment. Although effect sizes are small, there is consistent empirical evidence to support implementation of exercise as part of cancer care.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Kalter, Joeri
|b 1
700 1 _ |a Sweegers, Maike G
|b 2
700 1 _ |a Courneya, Kerry S
|b 3
700 1 _ |a Newton, Robert U
|b 4
700 1 _ |a Aaronson, Neil K
|b 5
700 1 _ |a Jacobsen, Paul B
|b 6
700 1 _ |a May, Anne M
|b 7
700 1 _ |a Galvão, Daniel A
|b 8
700 1 _ |a Chinapaw, Mai J
|b 9
700 1 _ |a Steindorf, Karen
|0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
|b 10
|u dkfz
700 1 _ |a Irwin, Melinda L
|b 11
700 1 _ |a Stuiver, Martijn M
|b 12
700 1 _ |a Hayes, Sandi
|b 13
700 1 _ |a Griffith, Kathleen A
|b 14
700 1 _ |a Lucia, Alejandro
|b 15
700 1 _ |a Mesters, Ilse
|b 16
700 1 _ |a van Weert, Ellen
|b 17
700 1 _ |a Knoop, Hans
|b 18
700 1 _ |a Goedendorp, Martine M
|b 19
700 1 _ |a Mutrie, Nanette
|b 20
700 1 _ |a Daley, Amanda J
|b 21
700 1 _ |a McConnachie, Alex
|b 22
700 1 _ |a Bohus, Martin
|b 23
700 1 _ |a Thorsen, Lene
|b 24
700 1 _ |a Schulz, Karl-Heinz
|b 25
700 1 _ |a Short, Camille E
|b 26
700 1 _ |a James, Erica L
|b 27
700 1 _ |a Plotnikoff, Ron C
|b 28
700 1 _ |a Arbane, Gill
|b 29
700 1 _ |a Schmidt, Martina
|0 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
|b 30
|u dkfz
700 1 _ |a Potthoff, Karin
|b 31
700 1 _ |a van Beurden, Marc
|b 32
700 1 _ |a Oldenburg, Hester S
|b 33
700 1 _ |a Sonke, Gabe S
|b 34
700 1 _ |a van Harten, Wim H
|b 35
700 1 _ |a Garrod, Rachel
|b 36
700 1 _ |a Schmitz, Kathryn H
|b 37
700 1 _ |a Winters-Stone, Kerri M
|b 38
700 1 _ |a Velthuis, Miranda J
|b 39
700 1 _ |a Taaffe, Dennis R
|b 40
700 1 _ |a van Mechelen, Willem
|b 41
700 1 _ |a Kersten, Marie-José
|b 42
700 1 _ |a Nollet, Frans
|b 43
700 1 _ |a Wenzel, Jennifer
|b 44
700 1 _ |a Wiskemann, Joachim
|0 P:(DE-He78)60b584aeef81e4c57fd111fa63779b73
|b 45
|u dkfz
700 1 _ |a Verdonck-de Leeuw, Irma M
|b 46
700 1 _ |a Brug, Johannes
|b 47
773 _ _ |a 10.1016/j.ctrv.2016.11.010
|g Vol. 52, p. 91 - 104
|0 PERI:(DE-600)2002084-3
|p 91 - 104
|t Cancer treatment reviews
|v 52
|y 2017
|x 0305-7372
909 C O |o oai:inrepo02.dkfz.de:119236
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 45
|6 P:(DE-He78)60b584aeef81e4c57fd111fa63779b73
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER TREAT REV : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER TREAT REV : 2015
920 1 _ |0 I:(DE-He78)G210-20160331
|k G210
|l Bewegung, Präventionsforschung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G210-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21